Fingerprint
Dive into the research topics of 'Multicenter phase II study of mogamulizumab (KW-0761), a defucosylated anti-CC chemokine receptor 4 antibody, in patients with relapsed peripheral T-cell lymphoma and cutaneous T-cell lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically